Gonadotropin-Releasing Hormone Agonists for Endometriosis

Abstract

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

• A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
• Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis via openalex
• Empirical therapy with leuprorelin acetate for endometriosis in the United States. via openalex
• Endometriosis: cost estimates and methodological perspective via openalex
• Endometriosis in Clinical Practice via openalex
• Epidemiology of endometriosis-associated infertility. via openalex
• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
• Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
• Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis via openalex
• Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
• “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
• Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
• PATHOGENESIS OF ENDOMETRIOSIS via openalex
• Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trial via openalex
• Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex
• Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis via openalex
• Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
• The role of add-back therapy in the United States. via openalex
• Treatment of Endometriosis via openalex
• Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
• Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
• W2028587418 via openalex
• W4232174123 via openalex
• W2073640827 via openalex
• W2015747176 via openalex
• W2077115943 via openalex
• W2063184348 via openalex
• W1973283880 via openalex
• W1966343709 via openalex
• W2172287852 via openalex
• W2322133447 via openalex
• W2405398988 via openalex
• W2408619637 via openalex

Cited by (39)

• Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
• Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) 2024
• Treatment of moderate-severe pain associated with early stage endometriosis; a consensus panel summary 2024
• Expectant, Medical, and Surgical Management of Ovarian Endometriomas 2023
• Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis 2023
• Treatment of moderate-severe pain associated with early stage endometriosis; a consensus panel summary 2023
• Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial 2022
• GnRH agonists in the treatment of symptomatic endometriosis: a review 2022
• Estrogen receptor beta promotes endometriosis progression by upregulating CD47 expression in ectopic endometrial stromal cells 2022
• Puberty in the Female and Its Disorders 2021
• New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments 2021
• Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial 2020
• Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study 2019
• Relationships between vitamin D receptor genetic polymorphisms and endometriosis in Korean women 2019
• GONADOTROPIN-RELEASING HORMONE AGONISTS IN ENDOMETRIOSIS TREATMENT AND IN VITRO FERTILIZATION 2018
• Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis 2018
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist 2018
• A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF 2018
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist 2017
• Adenomyosis in climacteric women 2015
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study 2015
• Possible association of maternal factors with the higher risk of isolated true undescended testis: A population‐based case‐control study 2014
• Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density 2014
• Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study 2013
• Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study 2013
• Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women. 2013
• Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients 2012
• Endometriosis and Chronic Pelvic Pain 2012
• Seven ways to preserve female fertility in patients with endometriosis 2012
• The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis 2012
• Acupuncture for pain in endometriosis 2011
• Endometriosis: Current and Emerging Therapies 2011
• Prävalenz von Depressionen und Angststörungen und ihre Einflussfaktoren bei Frauen mit Endometriose 2011
• Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? 2010
• Peritoneal Vascular Density Assessment Using Narrow-Band Imaging and Vascular Analysis Software, and Cytokine Analysis in Women With and Without Endometriosis 2009
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB and β-CATENIN Pathways and Activation of Intrinsic Apoptotic Mechanisms 2009
• Acupuncture for pain in endometriosis 2009
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms 2009
• Gonadotropin-Releasing Hormone Agonists for Endometriosis 2008

Source provenance

europepmc

last seen: 2026-09-13T09:25:22.628771+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:14:24.299271+00:00

unpaywall

last seen: 2026-09-13T06:26:10.529621+00:00